Vytorin Label Adds Superiority Data Over Crestor
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved the inclusion of new data on the cholesterol-lowering efficacy of the ezetimibe/simvastatin fixed-dose combination.